Connect to other sites within the UBM Medica Network
Stem Cells Identify Spread of Brain Disorders
The latest scientific developments about the brain and how it works were presented this week at the annual meeting of the Society for Neuroscience. Potential new treatments were identified.
New Imaging Spots Inflammation in Brain Disorders
These findings advance knowledge about the link between brain inflammation and the progression of brain disorders and suggest possible targets for future treatments.
Multiple Sclerosis Drug Lemtrada Gets FDA Nod
Approved for patients with relapsing forms of MS, the drug generally should be reserved for those who have had an inadequate response to 2 or more drugs indicated for MS treatment.
MRI May Advance Parkinson Gene Therapy
Up until now, these treatments have not produced promising efficacy results in clinical trials. MRI could show the way.
What MS Therapies Patients Want
As more treatments become available, patients will have more preferences and will play a more prominent role in directing choices.
New Migraine Links to Depression and Anxiety
Some very recent research findings have added to the literature on the associations between migraine and depression, anxiety, and other disorders. Highlights here.
MRI Predicts MS Risk, Even Without Symptoms
Determining who is at risk for MS remains difficult, and symptoms may take time to develop even in patients who already have some destroyed myelin. MRI may help.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.